跳至主要内容
临床试验/CTRI/2026/02/103132
CTRI/2026/02/103132尚未招募2 期

An open label comparative prospective clinical study to evaluate the efficacy of Vidangadi Loha Dwitiya with and without Vaman karma in the management of Pandu with special reference to Anemia

Dr Jyotiben H Parmar1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年2月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1

研究概览

简要总结

The present study is designed as an open label, comparative, prospective clinical trial to evaluate and compare the efficacy of Vidangadi loha Dwitiya administered with and without Vaman karma in the managment of pandu with special reference to anemia. The study aims to assess improvement in clinical feature of pandu and hematological parameter, thereby generating scientific evidence on the role of Sodhan assisted and Saman based ayurvedic management in pandu.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Participants of any gender aged 18–60 years and diagnosed with anemia 2.Hemoglobin level between 8–10.9gm/dl 3.Willing to provide written informed consent.

排除标准

  • 1.Patients with congenital hematological disorders (e.g. SCA, Hemophilia), Leukemia.
  • 2.Patients with uncontrolled bronchial asthma, cardiovascular disease, cerebrovascular disease.
  • 3.Patients with tuberculosis, HIV, or malignancy.
  • 4.Pregnant or lactating women.
  • 5.Known cases of renal dysfunction.

研究者

发起方
Dr Jyotiben H Parmar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Jyotiben H Parmar

Parul institute of Ayurved And Research Parul University

研究点 (1)

Loading locations...

相似试验

To Test the treatment effect of Ayurvedic medicine... | 临床试验